应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02348 东瑞制药
交易中 04-19 09:43:44
1.160
+0.000
0.00%
最高
1.160
最低
1.160
成交量
0.00
今开
1.160
昨收
1.160
日振幅
0.00%
总市值
17.40亿
流通市值
17.40亿
总股本
15.00亿
成交额
0.00
换手率
0.00%
流通股本
15.00亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
东瑞制药(02348)将于6月12日派发末期股息每股0.065港元
智通财经 · 03-26
东瑞制药(02348)将于6月12日派发末期股息每股0.065港元
港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%
智通财经 · 03-25
港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%
东瑞制药2023年收入下降9.9% 股东溢利减少8.95%
和讯网 · 03-25
东瑞制药2023年收入下降9.9% 股东溢利减少8.95%
东瑞制药盘中异动 早盘股价大跌9.16%
自选股智能写手 · 03-25
东瑞制药盘中异动 早盘股价大跌9.16%
东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%
新浪港股 · 03-25
东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%
东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙
智通财经 · 03-24
东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙
东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%
格隆汇资讯 · 03-22
东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%
东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%
智通财经 · 03-22
东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%
东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案
和讯网 · 03-08
东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案
东瑞制药盘中异动 大幅拉升5.08%报1.240港元
自选股智能写手 · 03-01
东瑞制药盘中异动 大幅拉升5.08%报1.240港元
东瑞制药(02348)股价上升5.085%,现价港币$1.24
阿斯达克财经 · 03-01
东瑞制药(02348)股价上升5.085%,现价港币$1.24
东瑞制药(02348)股价上升5.357%,现价港币$1.18
阿斯达克财经 · 02-19
东瑞制药(02348)股价上升5.357%,现价港币$1.18
【港股通】康方生物(09926)购康融东方35%股权 涉资2.67亿元人民币
金吾财讯 · 02-09
【港股通】康方生物(09926)购康融东方35%股权 涉资2.67亿元人民币
东瑞制药(02348.HK)向康方生物(09926.HK)悉售创新药物产品研发合资35%股权
阿斯达克财经 · 02-09
东瑞制药(02348.HK)向康方生物(09926.HK)悉售创新药物产品研发合资35%股权
东瑞制药拟出售康融东方35%股权
新浪港股 · 02-09
东瑞制药拟出售康融东方35%股权
东瑞制药(02348)拟出售康融东方35%股权
智通财经 · 02-09
东瑞制药(02348)拟出售康融东方35%股权
东瑞制药盘中异动 快速拉升5.92%报1.091港元
自选股智能写手 · 01-23
东瑞制药盘中异动 快速拉升5.92%报1.091港元
东瑞制药盘中异动 下午盘快速拉升5.81%报1.111港元
自选股智能写手 · 2023-10-27
东瑞制药盘中异动 下午盘快速拉升5.81%报1.111港元
加载更多
公司概况
公司名称:
东瑞制药
所属市场:
SEHK
上市日期:
--
主营业务:
东瑞制药(控股)有限公司是一家投资控股公司,主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。
发行价格:
--
{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":1.16,"timestamp":1713488400064,"preClose":1.16,"halted":0,"volume":0,"delay":0,"floatShares":1500397000,"shares":1500397000,"eps":0.23453829,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"04-19 09:43:44","open":1.16,"high":1.16,"low":1.16,"amount":0,"amplitude":0,"askPrice":1.23,"askSize":20000,"bidPrice":1.13,"bidSize":12000,"shortable":0,"etf":0,"ttmEps":0.23411968201754385,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1713499200000},"adr":0,"adjPreClose":1.16,"dividendRate":0.067628,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"2422663504","title":"东瑞制药(02348)将于6月12日派发末期股息每股0.065港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422663504","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422663504?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:07","pubTimestamp":1711444060,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药(02348)发布公告,将于2024年6月12日派发截至2023年12月31日止年度的末期股息每股0.065港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092355.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422539013","title":"港股异动 | 东瑞制药(02348)跌超10% 2023年股东应占溢利3.26亿元 同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422539013","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422539013?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:26","pubTimestamp":1711333581,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,东瑞制药跌超10%,截止发稿跌12.88%,报1.15港元,成交额154万港元。消息面上,公司发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元,同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。公告称,中间体及原料药销售额人民币1.29亿元,比去年下降7.8%,销售额减少人民币1102.2万元;成药销售额人民币10.22亿元,比去年下降10.2%,销售额减少人民币1.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091249.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422536813","title":"东瑞制药2023年收入下降9.9% 股东溢利减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422536813","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2422536813?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:44","pubTimestamp":1711331095,"startTime":"0","endTime":"0","summary":"快讯摘要东瑞制药2023年业绩报告显示,公司收入11.51亿元,同比下降9.9%,股东应占溢利3.26亿元,同比减少8.95%。面对激烈市场竞争,公司采取降低成本和提高效率措施。尽管如此,业绩下降反映出东瑞制药在2023年面临的挑战。投资者关注公司未来策略及应对市场竞争的能力。末期股息计划派发每股0.065港元。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250957058b5f1190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250957058b5f1190&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422587721","title":"东瑞制药盘中异动 早盘股价大跌9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422587721","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422587721?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:30","pubTimestamp":1711330204,"startTime":"0","endTime":"0","summary":"2024年03月25日早盘09时30分,东瑞制药股票出现异动,股价快速跳水9.16%。截至发稿,该股报1.200港元/股,成交量13.2万股,换手率0.01%,振幅3.79%。东瑞制药股票所在的药品行业中,整体跌幅为0.10%。其相关个股中,三爱健康集团、康龙化成、四环医药涨幅较大,振幅较大的相关个股有三爱健康集团、东瑞制药、石药集团,振幅分别为4.44%、3.79%、0.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250930047a4eb80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403250930047a4eb80f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422584953","title":"东瑞制药发布2023年度业绩 股东应占溢利3.26亿元同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422584953","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422584953?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:44","pubTimestamp":1711327466,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元(人民币,下同),同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0122802.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0122802.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421266913","title":"东瑞制药(02348)将于6月12日派发末期股息每股6.5港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2421266913","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421266913?lang=zh_cn&edition=full","pubTime":"2024-03-24 18:16","pubTimestamp":1711275392,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药(02348)公布,将于2024年6月12日派发末期股息每股6.5港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091116.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421435548","title":"东瑞制药(02348.HK)年度母公司拥有人应占溢利约3.26亿元 同比下降约9.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421435548","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2421435548?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:03","pubTimestamp":1711119788,"startTime":"0","endTime":"0","summary":"格隆汇3月22日丨东瑞制药(02348.HK)发布公告,截至2023年12月31日止年度,公司录得收入约人民币11.5亿元,同比减少约9.9%。母公司拥有人应占溢利约人民币3.26亿元,同比下降约9.0%。董事会建议派发年度末期股息每股为港币0.065元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223031587a7f175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223031587a7f175&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421848182","title":"东瑞制药(02348)发布年度业绩 股东应占溢利3.26亿元 同比减少8.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421848182","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421848182?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:01","pubTimestamp":1711119684,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药 发布截至2023年12月31日止年度的全年业绩,该集团期内取得收入11.51亿元,同比减少9.9%;股东应占溢利3.26亿元,同比减少8.95%;每股基本盈利0.2174元;拟派发末期股息每股0.065港元。公告称,中间体及原料药销售额人民币1.29亿元,比去年下降7.8%,销售额减少人民币1102.2万元;成药销售额人民币10.22亿元,比去年下降10.2%,销售额减少人民币1.16亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091031.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417305822","title":"东瑞制药(02348.HK)董事会会议将审议2023年报及派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2417305822","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2417305822?lang=zh_cn&edition=full","pubTime":"2024-03-08 19:53","pubTimestamp":1709898800,"startTime":"0","endTime":"0","summary":"快讯正文东瑞制药即将召开董事会会议以批准去年年报及考虑派息事宜。东瑞制药宣布,董事会将于3月22日举行会议。会议议程包括批准公司及其附属公司2023年度的业绩公告。此外,董事会还将讨论是否建议派发末期股息。投资者可关注此次会议结果,以获取公司最新的财务信息。和讯自选股写手风险提示:以上内容仅作为作者或者嘉宾的观点,不代表和讯的任何立场,不构成与和讯相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082017168b182fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082017168b182fe1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416524056","title":"东瑞制药盘中异动 大幅拉升5.08%报1.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416524056","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416524056?lang=zh_cn&edition=full","pubTime":"2024-03-01 13:26","pubTimestamp":1709270809,"startTime":"0","endTime":"0","summary":"2024年03月01日下午盘13时26分,东瑞制药股票出现异动,股价大幅拉升5.08%。截至发稿,该股报1.240港元/股,成交量22万股,换手率0.01%,振幅5.08%。资金方面,该股资金流入19.544万港元,流出6.288万港元。东瑞制药股票所在的药品行业中,整体跌幅为0.26%。其相关个股中,艾美疫苗、中生联合、培力农本方涨幅较大,振幅较大的相关个股有前海健康、艾美疫苗、三爱健康集团,振幅分别为41.38%、16.62%、13.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011326497a486bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011326497a486bf1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416756652","title":"东瑞制药(02348)股价上升5.085%,现价港币$1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2416756652","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2416756652?lang=zh_cn&edition=full","pubTime":"2024-03-01 13:26","pubTimestamp":1709270760,"startTime":"0","endTime":"0","summary":"[上升股]东瑞制药(02348) 股价在下午01:26比前收市价上升5.085%,现股价为港币$1.24。至目前为止,今日最高价为$1.24,而最低价为$1.18。总成交量为22万股,总成交金额为港币$26.8万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403012015/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2412492201","title":"东瑞制药(02348)股价上升5.357%,现价港币$1.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2412492201","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2412492201?lang=zh_cn&edition=full","pubTime":"2024-02-19 11:24","pubTimestamp":1708313040,"startTime":"0","endTime":"0","summary":"[上升股]东瑞制药(02348) 股价在上午11:24比前收市价上升5.357%,现股价为港币$1.18。至目前为止,今日最高价为$1.18,而最低价为$1.12。总成交量为41.6万股,总成交金额为港币$47.928万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2402192007/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2410377769","title":"【港股通】康方生物(09926)购康融东方35%股权 涉资2.67亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2410377769","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2410377769?lang=zh_cn&edition=full","pubTime":"2024-02-09 09:16","pubTimestamp":1707441371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康方生物(09926)的间接全资附属公司购买康融东方35%股权。完成收购事项后,康融东方将成为公司的间接全资附属公司。代价为2.67亿元人民币。康融东方是一家集抗体药物开发、生产和销售于一体的创新生物制药公司,由买方以技术和产品注入,卖方以资金注入的形式,于2016年12月合资成立。康融东方紧跟科学发展前沿,专注心血管,肿瘤等重大疾病的创新药物及联合疗法的创新开发。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1931397","is_publish_highlight":false,"gpt_icon":0},{"id":"2410774772","title":"东瑞制药(02348.HK)向康方生物(09926.HK)悉售创新药物产品研发合资35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2410774772","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2410774772?lang=zh_cn&edition=full","pubTime":"2024-02-09 08:33","pubTimestamp":1707438780,"startTime":"0","endTime":"0","summary":"东瑞制药公布,其全资附属东瑞生物向康方生物的全资附属中山康方,悉售东瑞生物于康融东方的35%股权,购买价为2.67亿元人民币(下同)。因此,东瑞生物根据该协议有权收取合共3.9亿元。东瑞制药估计出售事项将确认税前收益净额约2.67亿至2.85亿元,出售所得资源将用于研发项目以及制造及销售活动。康方生物认为,将康融东方创新药物产品全面融入公司旗下肿瘤和非肿瘤产品管线,将有利于该两款产品后续临床开发及商业计划的整体高效运作。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190723164448759_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190723164448759_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1325977/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2410177121","title":"东瑞制药拟出售康融东方35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2410177121","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2410177121?lang=zh_cn&edition=full","pubTime":"2024-02-09 08:05","pubTimestamp":1707437119,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布公告,于2024年2月8日,公司的全资附属公司东瑞生物与中山康方(作为买方) 、康方生物(作为中山康方付款责任的担保人)及康融东方(作为目标公司)订立该协议,据此,东瑞生物同意出售及中山康方同意购买东瑞生物于康融东方的35%股权,购买价为人民币2.67亿元。\n 该协议亦要求康融东方偿还该等贷款及截至2024年2月8日的应计利息。因此,东瑞生物根据该协议有权收取合共人民币3.9亿元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-09/doc-inahkvxs3666788.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-09/doc-inahkvxs3666788.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2410477696","title":"东瑞制药(02348)拟出售康融东方35%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2410477696","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2410477696?lang=zh_cn&edition=full","pubTime":"2024-02-09 07:21","pubTimestamp":1707434495,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东瑞制药 发布公告,于2024年2月8日,公司的全资附属公司东瑞生物与中山康方 、康方生物及康融东方订立该协议,据此,东瑞生物同意出售及中山康方同意购买东瑞生物于康融东方的35%股权,购买价为人民币2.67亿元。该协议亦要求康融东方偿还该等贷款及截至2024年2月8日的应计利息。因此,东瑞生物根据该协议有权收取合共人民币3.9亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1071321.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2405199041","title":"东瑞制药盘中异动 快速拉升5.92%报1.091港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405199041","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405199041?lang=zh_cn&edition=full","pubTime":"2024-01-23 14:05","pubTimestamp":1705989949,"startTime":"0","endTime":"0","summary":"2024年01月23日下午盘14时05分,东瑞制药股票出现波动,股价快速拉升5.92%。截至发稿,该股报1.091港元/股,成交量22万股,换手率0.01%,振幅2.91%。资金方面,该股资金流入17.264万港元,流出0港元。东瑞制药股票所在的药品行业中,整体涨幅为0.23%。其相关个股中,德琪医药-B、中国生物制药、东瑞制药涨幅较大,振幅较大的相关个股有中生联合、联康生物科技集团、德琪医药-B,振幅分别为16.26%、14.13%、10.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123140549861ccbd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123140549861ccbd0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2378849737","title":"东瑞制药盘中异动 下午盘快速拉升5.81%报1.111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2378849737","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2378849737?lang=zh_cn&edition=full","pubTime":"2023-10-27 14:16","pubTimestamp":1698387372,"startTime":"0","endTime":"0","summary":"2023年10月27日下午盘14时16分,东瑞制药股票出现波动,股价大幅拉升5.81%。截至发稿,该股报1.111港元/股,成交量4.8万股,换手率0.00%,振幅5.71%。东瑞制药股票所在的药品行业中,整体涨幅为1.32%。其相关个股中,翰森制药、中国生物制药、石药集团涨幅较大,振幅较大的相关个股有翰森制药、中国生物制药、信达生物,振幅分别为13.81%、13.53%、12.17%。消息层面,截至14时16分,东瑞制药股票正面舆情新闻比例100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231027141613806a56f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231027141613806a56f9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":-0.0333},{"period":"1month","weight":-0.1278},{"period":"3month","weight":0.0841},{"period":"6month","weight":0.1048},{"period":"1year","weight":-0.0638},{"period":"ytd","weight":0.1048}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药(控股)有限公司是一家投资控股公司,主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.003117},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.004372},{"month":3,"riseRate":0.47619,"avgChangeRate":0.022465},{"month":4,"riseRate":0.666667,"avgChangeRate":0.039675},{"month":5,"riseRate":0.45,"avgChangeRate":0.012027},{"month":6,"riseRate":0.55,"avgChangeRate":0.00814},{"month":7,"riseRate":0.55,"avgChangeRate":0.017806},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.015772},{"month":9,"riseRate":0.47619,"avgChangeRate":0.02338},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.004691},{"month":11,"riseRate":0.571429,"avgChangeRate":0.040096},{"month":12,"riseRate":0.571429,"avgChangeRate":0.014202}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}